Back to Treatments

Treatment

Linezolid (as component of XDR-TB regimen)

1
Conditions
50
Trials
10K
Participants
34%
Average Safety

Condition Evidence

HIV/AIDS - Extensively drug-resistant Tuberculosis

50 trials · 10K participants

80% effectiveness · 34% safety
Linezolid (as component of XDR-TB regimen) | DFDA